Study of AR-14034 in Participants with Neovascular Age-Related Macular Degeneration (nAMD)

Recruiting

Phase 1

Phase 2

Study of AR-14034 in Participants with Neovascular Age-Related Macular Degeneration (nAMD)Study of AR-14034 in Participants with Neovascular Age-Related Macular Degeneration (nAMD)

Sponsor:

Alcon Research

Code:

NCT05769153

Conditions

Neovascular Age-related Macular Degeneration (nAMD)

Eligibility Criteria

Sex: All

Age: 50+

Healthy Volunteers: Not accepted

Interventions

AR-14034 SR implant lower dose

Aflibercept Injection

Sham procedure

AR-14034 SR implant higher dose

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-28. This information was provided to ClinicalTrials.gov by Alcon Research on 2024-11-25.